439P: Standardization of endpoints in early NSCLC randomized clinical trials (RCTs): The DATECAN initiative
2025 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/s1556-0864(25)00631-8
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
0
Citations
0
h-index
0
i10-index
N. Cozic is an academic researcher from Inserm. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lymphoma Diagnosis and Treatment & Lung Cancer Treatments and Mutations.
Click to start Chat